Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 89.02M P/E - EPS this Y -58.50% Ern Qtrly Grth -
Income -72.11M Forward P/E -0.97 EPS next Y 1.90% 50D Avg Chg -27.00%
Sales 689k PEG - EPS past 5Y - 200D Avg Chg -34.00%
Dividend N/A Price/Book 4.39 EPS next 5Y - 52W High Chg -90.00%
Recommedations 2.00 Quick Ratio 1.76 Shares Outstanding 91M 52W Low Chg 19.00%
Insider Own 10.17% ROA -73.62% Shares Float 81.74M Beta 0.46
Inst Own 13.52% ROE -196.73% Shares Shorted/Prior 4.65M/6.56M Price 0.98
Gross Margin -38.46% Profit Margin - Avg. Volume 955,498 Target Price 5.44
Oper. Margin -11,096.81% Earnings Date Nov 14 Volume 397,465 Change 1.75%
PAVmed Inc. News
08/30/22 PAVmed to Participate in the Lake Street 6th Annual Best Ideas Growth Conference and the A.G.P. Virtual MedTech Conference
08/17/22 Does PAVmed (NASDAQ:PAVM) Have A Healthy Balance Sheet?
08/16/22 PAVmed Provides Business Update and Preliminary Second Quarter 2022 Financial Results
08/15/22 Lucid Diagnostics Provides Business Update and Preliminary Second Quarter 2022 Financial Results
08/11/22 Lucid Diagnostics Launches Stage II Lucid Test Center Expansion in California, Texas, Florida, and Ohio
08/04/22 Newly Published American Gastroenterological Association Clinical Practice Update Supports Esophageal Precancer Screening Using Lucid Diagnostics’ EsoGuard® and EsoCheck® Technologies
08/03/22 PAVmed to Hold a Business Update Conference Call on August 16, 2022
07/19/22 PAVmed Chairman & CEO Lishan Aklog, M.D. Named to Savoy’s 2022 Most Influential Black Executives in Corporate America
07/18/22 Lucid Diagnostics to Participate in the Canaccord 42nd Annual Growth Conference and the 7th Annual Needham Med Tech & Diagnostics 1x1 Conference
05/13/22 PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare Technology CEO
05/12/22 PAVmed PAVmed Provides Business Update and Preliminary First Quarter 2022 Financial Results
05/11/22 Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial Results
05/09/22 Lucid Diagnostics’ Laboratory Executes Participating Provider Agreement with MediNcrease Health Plans
05/04/22 Lucid Diagnostics Selects Veeva Vault CDMS for EsoGuard® Study
04/28/22 PAVmed Announces Procedural Update on its Settlement of a Previously Disclosed Class Action Lawsuit
07:25 AM PAVmed to Hold a Business Update Conference Call on May 12, 2022
04/25/22 Lucid Diagnostics to Hold a Business Update Conference Call on May 11, 2022
04/04/22 Lucid Diagnostics Provides Updates on Newly Published Esophageal Precancer Clinical Guideline and Proposed Medicare Local Coverage Determination
03/30/22 Lucid Diagnostics to Participate in the Needham 21st Annual Healthcare Conference

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; Veris cancer healthcare platform and implantable intelligent vascular port combining remote monitoring and data analytics; NextVent single-use ventilators; FlexMO medical circulatory support cannulas; Veris cardiac monitors; DisappEAR resorbable pediatric ear tubes; Solys noninvasive glucose monitoring. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.

PAVM Chatroom

User Image TSLA_S3XY Posted - 1 day ago

$PAVM

User Image coinalyst Posted - 1 day ago

$PAVM very bullish. .eoy 5$ pt

User Image TSLA_S3XY Posted - 1 day ago

$PAVM

User Image Nightwolf6502 Posted - 2 days ago

$PAVM This stock has become quite boring to follow, no denying that. What is certain to me, however, is great stuff is going on in the background which is slow and steady growth that will lead this company to being worth a few billion dollars if you're willing to wait (and hold) long enough for the success of eso to pan out. It really sucks only getting updates once per quarter, but it's how this company operates - just gotta have faith to hold long term here.

User Image UncleJuniorrr Posted - 2 days ago

$PAVM

User Image My_Lai_1968 Posted - 2 days ago

$PAVM You got a big time winner here.

User Image Jswizzle Posted - 2 days ago

$PAVM we are recession proof. Lol

User Image chaptal Posted - 2 days ago

The only green in my portfolio. Hilarious. $PAVM

User Image minnesotafarmcountry Posted - 2 days ago

$PAVM Anyone else seeing the bright side today … could be much worse today, anyway 🤷‍♀️

User Image Prizzz Posted - 2 days ago

$PAVM He didnt have 50K in his bank to cover the taxes, he had to sell his shares? Like damn, where is the reassuring confidence from management ?

User Image Prizzz Posted - 2 days ago

$PAVM Welp, i feel like a jackass for that 1.04 buy .. We may see new all time lows and not see over 1$ for a whileee ! NO insider buying and now we get this from Stanley ... His hire just feels like a massive pump .. What value is he bringing ..? Seems like none..

User Image TheRightStuff Posted - 3 days ago

$PAVM imo, stanley selling his Lucid shares is terrible. do not care if it was for tax or not. This company has done nothing, but overpromise, and underdeliver. Terrible news.

User Image Hacko Posted - 3 days ago

$PAVM Is PharmaD buying the dip?

User Image sophia1987 Posted - 3 days ago

$PAVM final kiss of death

User Image BidaskBot Posted - 3 days ago

PAVmed $PAVM BidaskScore is Downgraded to Held https://bidaskclub.com/news/company/2022-09-21/PAVM

User Image sistermojo Posted - 3 days ago

$PAVM okay so the director of lucid Diagnostics is selling shares did he buy them or acquire them that does make a big difference but still to be selling them at $1.70?

User Image graniterock Posted - 3 days ago

$PAVM this sp last time it happened then on its way to over $2 ,hopefully the price stays here till I can free up some funds ,will it repeat ?

User Image Boochook Posted - 3 days ago

$PAVM I’m running out of Dramamine to live through these swings. 😂😂😂😂

User Image midnite_clyde Posted - 3 days ago

$PAVM DJDan!! Gotta song request!!! 96 Tears by Question Mark and The Mysterians!! You should be familiar with that by now!!

User Image LouElse Posted - 3 days ago

$PAVM what will recover first XBI or this?

User Image TheRightStuff Posted - 3 days ago

$PAVM 😥

User Image Investbythenumbers Posted - 3 days ago

$PAVM READ! 💥 $LUCD

User Image BioDisaster21 Posted - 3 days ago

$LPTX $PAVM $AFMD $PDSB $ONCT No bottom , everything going to pennies

User Image Investbythenumbers Posted - 3 days ago

$PAVM Key words, “to cover taxes.” This is a nothing burger, accumulate and wait 18 - 30 months!

User Image LouElse Posted - 3 days ago

$PAVM we gave him shares to do what?

User Image TopCharts Posted - 3 days ago

$PAVM back under a $1 for twenty time how surprising

User Image traderjoe2018 Posted - 3 days ago

$PAVM Stanley sold a bunch of LUCD recently. So there’s that.

User Image DrKyle Posted - 3 days ago

$PAVM last i checked people were still eating like complete crap...nothing has changed here

User Image LouElse Posted - 3 days ago

$PAVM I will buy in 6-9 months

User Image sistermojo Posted - 3 days ago

$PAVM this is so bad but anybody that sold pav mad after we dropped and moved it into lucid got f*****

Analyst Ratings
Lake Street Buy Aug 17, 22
Cantor Fitzgerald Overweight Mar 30, 21
Ascendiant Capital Buy Nov 5, 20
Lake Street Buy Oct 13, 20
Maxim Group Buy Jun 28, 18